Clinical Pearls for Optimizing RSV Vaccination in Adult Patients

home / peer-exchange / clinical-pearls-for-optimizing-rsv-vaccination-in-adult-patients

Traci M. Poole, PharmD, BCACP, BCGP, discusses how optimizing respiratory syncytial virus (RSV) vaccination in adult patients, particularly those at high risk, involves best practices for maximizing vaccine uptake, understanding FDA-approved vaccine options, and addressing vaccine hesitancy through the role of the pharmacist.

Important Background Information on RSV for Pharmacists

EP. 1: Important Background Information on RSV for Pharmacists

Traci M. Poole, Pharm.D., BCACP, BCGP
December 20th 2024

Traci M. Poole, PharmD, BCACP, BCGP, discusses the pathophysiology of respiratory syncytial virus (RSV) and its key complications, identifies high-risk populations for severe RSV infection, and explores best practices for recognizing these patients and ensuring they receive timely vaccination to prevent serious outcomes.

Watch